Arlington, Va—While influenza pandemics have long posed a threat to humankind—a threat realized to varying extents in 1918, 1957, and 1968—particular concern has mounted of late due to continued sporadic human cases of H5N1 avian influenza in Southeast Asia, Eastern Europe, and Africa. Experts met recently to discuss how best to prepare in the United States for a potential H5N1 pandemic, including a process for development and distribution of effective vaccines and antiviral drugs.
Hampton T. Drug, Vaccine Research Target Avian Flu. JAMA. 2007;297(11):1179-1180. doi:10.1001/jama.297.11.1179